Skip to main content
SpringerLink
Log in

Leading Pharmaceutical Innovation

Trends and Drivers for Growth in the Pharmaceutical Industry

  • Book
  • © 2004

Overview

Authors:
  1. Oliver Gassmann

    1. Institute of Technology Management, University of St. Gallen, St. Gallen, Switzerland

    View author publications

    You can also search for this author in PubMed   Google Scholar

  2. Gerrit Reepmeyer

    1. Institute of Technology Management, University of St. Gallen, St. Gallen, Switzerland

    View author publications

    You can also search for this author in PubMed   Google Scholar

  3. Maximilian Zedtwitz

    1. School of Economics and Management, Tsinghua University, Beijing, People’s Republic of China
      IMD-International, Lausanne, Switzerland

    View author publications

    You can also search for this author in PubMed   Google Scholar

  • The book is based on the three most important challenges in pharmaceutical innovation: productivity dilemma, new technology trends, globalization and outsourcing
  • Due to the CTO-roundtable with 14 selected international experts in pharmaceutical R&D whose result is presented, the book has a strong perspective from senior management
  • With management concepts and tools enabling leaders in the pharmaceutical industry to cope with new challenges and trends
  • Includes supplementary material: sn.pub/extras

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (8 chapters)

  1. Front Matter

    Pages i-xi
    Download chapter PDF

  2. Innovation as a Key Success Factor in the Pharmaceutical Industry

    • Oliver Gassmann, Gerrit Reepmeyer, Maximilian von Zedtwitz
    Pages 1-22

  3. Pharmaceutical Innovation: The Case of Switzerland

    • Oliver Gassmann, Gerrit Reepmeyer, Maximilian von Zedtwitz
    Pages 23-52

  4. The Science and Technology Challenge: How to Find New Drugs

    • Oliver Gassmann, Gerrit Reepmeyer, Maximilian von Zedtwitz
    Pages 53-69

  5. The Pipeline Management Challenge: How to Shape the Innovation-Flow

    • Oliver Gassmann, Gerrit Reepmeyer, Maximilian von Zedtwitz
    Pages 71-85

  6. The Outsourcing and Internationalization Challenge: How to Harness Outside Innovation

    • Oliver Gassmann, Gerrit Reepmeyer, Maximilian von Zedtwitz
    Pages 87-115

  7. Management Answers to Pharmaceutical R&D Challenges

    • Oliver Gassmann, Gerrit Reepmeyer, Maximilian von Zedtwitz
    Pages 117-138

  8. Future Directions and Trends

    • Oliver Gassmann, Gerrit Reepmeyer, Maximilian von Zedtwitz
    Pages 139-142

  9. Appendices

    • Oliver Gassmann, Gerrit Reepmeyer, Maximilian von Zedtwitz
    Pages 143-157

  10. Back Matter

    Pages 159-178
    Download chapter PDF
Back to top

Keywords

About this book

Pharmaceutical innovation is like gambling at roulette, only the stakes are higher. Considerably higher, since the most recent estimates put the costs of drug development at US$ 800 million to US$ 1 billion - per drug! This is equivalent to the price tag of the Empire State Building, when it was for sale a few years ago. In 2001, the major US and European pharmaceutical companies invested more than US$ 30 billion in R&D, at a higher R&D­ to-sales ratio than virtually any other industry, including chemicals, auto­ mobiles, electronics, aerospace, and computers. Delivering a blockbuster drug is the Holy Grail for any pharmaceutical company. But in the last decade the rules of developing blockbusters seem to have changed. On the one hand, more sophisticated screening technolo­ gies, genetic engineering, and expanding networks with biotechnology companies increase the probability of commercial success. Critical success factors include the discovery phase and a stronger outside-in orientation in the early innovation phase. After the implosion of the high-tech stock mar­ ket, biotechnology and other technology-driven opportunities may have lost some of their attractiveness for big pharma: a pipeline of solid and predictable innovations seems to be the highest goal of most pharmaceuti­ cal companies again. On the other hand, despite significant investments in pipeline management and novel technologies, there is still no recipe for ensuring a blockbuster hit.

Reviews

From the reviews:

"This book examines the international pharmaceutical industry with special emphasis on the current and emerging research methodologies … . What distinguishes this book from others on the same subject is its emphasis on empirical findings (53 figures, 20 tables) and an exceptionally good, if short, discussion of various research technologies … . The six-page glossary of industry terms, when used with its decent index, is a particular joy. … recommend this offering to prospective managers and researchers in this industry … ." (Robert R. Rothberg, Journal of Product Innovation Management, Vol. 22, 2005)

Authors and Affiliations

  • Institute of Technology Management, University of St. Gallen, St. Gallen, Switzerland

    Oliver Gassmann, Gerrit Reepmeyer

  • School of Economics and Management, Tsinghua University, Beijing, People’s Republic of China

    Maximilian Zedtwitz

  • IMD-International, Lausanne, Switzerland

    Maximilian Zedtwitz

Bibliographic Information

  • Book Title: Leading Pharmaceutical Innovation

  • Book Subtitle: Trends and Drivers for Growth in the Pharmaceutical Industry

  • Authors: Oliver Gassmann, Gerrit Reepmeyer, Maximilian Zedtwitz

  • DOI: https://doi.org/10.1007/978-3-540-24781-4

  • Publisher: Springer Berlin, Heidelberg

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer-Verlag Berlin Heidelberg 2004

  • eBook ISBN: 978-3-540-24781-4Published: 05 June 2013

  • Edition Number: 1

  • Number of Pages: XI, 178

  • Topics: Innovation/Technology Management, Pharmacy, Public Health, R & D/Technology Policy

Publish with us

Policies and ethics

Back to top

Search

Navigation